Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neuroimmunol ; 233(1-2): 221-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21239064

ABSTRACT

The aim was to ascertain any possible linkage between humoral immune responses to principal biomarkers (α-synuclein monomers, its toxic oligomers or fibrils, dopamine and S100B) and cellular immunity in Parkinson's disease development. There were elevated autoantibody titers to α-synuclein monomers, oligomers plus fibrils in 72%, 56%, and 17% of Parkinsonian patients respectively with a 5-year disease duration. Additionally, there were increased titers to dopamine and S100B (96% and 89%) in the 5-year patient group. All of these values subsided in 10-year sufferers. Furthermore, CD3+, CD4+, CD8+ T-lymphocyte and B-lymphocyte subsets declined in the patient cohort during Parkinsonism indicating disease associated reductions in these lymphocyte subsets.


Subject(s)
Parkinson Disease/immunology , Parkinson Disease/metabolism , Autoantibodies/biosynthesis , Autoantibodies/blood , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/metabolism , B-Lymphocyte Subsets/pathology , Cohort Studies , Disease Progression , Dopamine/immunology , Dopamine/toxicity , Female , Humans , Male , Middle Aged , Nerve Growth Factors/immunology , Nerve Growth Factors/toxicity , Parkinson Disease/pathology , S100 Calcium Binding Protein beta Subunit , S100 Proteins/immunology , S100 Proteins/toxicity , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/pathology , alpha-Synuclein/immunology , alpha-Synuclein/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...